Kaken Pharmaceutical obtains approval in Japan for additional doses and indication of Ebutol May 30, 2011
Gactiv approved in Japan for type 2 diabetes in combination with alpha-glucosidase inhibitors May 24, 2011
European Commission approves Eliquis for prevention of VTE after hip or knee replacement May 23, 2011
RSS